Protagonist Therapeutics, Inc. (PTGX) Social Stream
PROTAGONIST THERAPEUTICS INC (PTGX) Price Targets From Analysts
Use the tables below to see what analysts covering PROTAGONIST THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-14 | 7 | $93 | $40 | $56.857 | $25.39 | 123.93% |
| 2021-11-15 | 7 | $93 | $40 | $58.285 | $25.39 | 129.56% |
| 2022-01-27 | 8 | $93 | $40 | $59 | $25.39 | 132.37% |
| 2022-03-02 | 8 | $93 | $40 | $58.5 | $25.39 | 130.41% |
| 2022-04-25 | 8 | $93 | $40 | $58 | $25.39 | 128.44% |
| 2022-04-26 | 8 | $93 | $40 | $56.75 | $25.39 | 123.51% |
| 2022-05-05 | 8 | $93 | $30 | $51.75 | $25.39 | 103.82% |
| 2022-05-06 | 8 | $70 | $30 | $47.625 | $25.39 | 87.57% |
| 2022-05-09 | 8 | $70 | $30 | $46.875 | $25.39 | 84.62% |
| 2022-05-17 | 8 | $70 | $30 | $43.75 | $25.39 | 72.31% |
| 2022-07-21 | 6 | $70 | $30 | $44.166 | $25.39 | 73.95% |
| 2022-08-05 | 6 | $70 | $30 | $44.285 | $25.39 | 74.42% |
| 2022-08-25 | 7 | $50 | $21 | $37.285 | $25.39 | 46.85% |
| 2022-09-28 | 7 | $50 | $21 | $36 | $25.39 | 41.79% |
| 2022-11-09 | 6 | $50 | $21 | $37 | $25.39 | 45.73% |
| 2023-01-17 | 6 | $45 | $21 | $34.166 | $25.39 | 34.56% |
| 2023-03-08 | 4 | $45 | $31 | $35.833 | $25.39 | 41.13% |
| 2023-03-16 | 5 | $45 | $31 | $36.666 | $25.39 | 44.41% |
| 2023-03-20 | 5 | $45 | $29 | $35.666 | $25.39 | 40.47% |
| 2023-05-08 | 5 | $38 | $29 | $33.8 | $25.39 | 33.12% |
| 2023-05-12 | 5 | $38 | $30 | $34 | $25.39 | 33.91% |
| 2023-05-25 | 5 | $40 | $31 | $36 | $25.39 | 41.79% |
| 2023-07-03 | 6 | $49 | $31 | $37.8 | $25.39 | 48.88% |
| 2023-08-04 | 6 | $49 | $35 | $39 | $25.39 | 53.6% |
| 2023-09-25 | 6 | $49 | $34 | $39.4 | $25.39 | 55.18% |
| 2023-11-03 | 6 | $49 | $32 | $38.166 | $25.39 | 50.32% |
| 2023-11-15 | 6 | $49 | $32 | $38.5 | $25.39 | 51.63% |
| 2023-12-05 | 6 | $49 | $34 | $40.166 | $25.39 | 58.2% |
The Trend in the Analyst Price Target
PTGX's average price target has moved up $13.17 over the prior 43 months.
PTGX reports an average of 93.94% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-16 | 5 | 45 | 29 | 35.666 | 23.15 | 54.06% |
| 2023-05-04 | 5 | 38 | 29 | 33.800 | 23.60 | 43.22% |
| 2023-05-08 | 5 | 38 | 30 | 34.000 | 24.93 | 36.38% |
| 2023-07-06 | 6 | 49 | 35 | 39.000 | 23.66 | 64.84% |
| 2023-08-04 | 6 | 49 | 35 | 39.000 | 19.18 | 103.34% |
PTGX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 13 months, PTGX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PROTAGONIST THERAPEUTICS INC's variance in analysts' estimates is lower than -2449.55% of them.
- PTGX has a greater upside potential (average analyst target price relative to current price) than 2714.62% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, PROTAGONIST THERAPEUTICS INC's number of analysts covering the stock is higher than 1115.98% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PROTAGONIST THERAPEUTICS INC's average analyst price target is higher than 2415.46% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROTAGONIST THERAPEUTICS INC are XENE, CMRX, and NKTX.
View All Top Stocks by Price Target
Is PTGX a Buy, Hold or Sell? See the POWR Ratings now!